One of Warren Buffett’s oddest stock holdings is the Israeli/American drug maker Teva Pharmaceutical Industries Ltd (NYSE: TEVA).
Teva is cheap; trading at $13.30 a share on 20 February 2020. However, Teva’s revenue growth, and gross profit are shrinking.
Teva’s quarterly gross profit fell from $1.977 billion on 30 September 2018 to $1.829 billion a year later. Between September 2018 and September 2019, Teva suffered four quarters of revenue growth shrinkage.